Navigation Links
IRIDEX Announces Second Quarter 2008 Conference Call and Release Date
Date:8/5/2008

MOUNTAIN VIEW, Calif., Aug. 5 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its second quarter 2008 financial results after the market closes on Tuesday, August 12, 2008. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Tuesday, August 12, 2008 to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by dialing (800) 366-7449 (US) or (303) 262-2143 (International), or by visiting the Company's website at http://www.iridex.com. A telephone replay will be available beginning on Tuesday, August 12, 2008 through Tuesday, August 19, 2008 by dialing (800) 405-2236 (US) or (303) 590-3000 (International) and entering Passcode 11118106#.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. IRIDEX Announces James Mackaness Will Be Chief Financial Officer
2. Pollogen Announces Appointment of Ms. Yfat Scialom as Chief Executive Officer
3. Molecular Biometrics Announces Results of Parkinsons Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology
4. SemBioSys announces second quarter 2008 financial and operational results
5. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
6. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
7. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
8. NanoLogix Inc. Announces Joint Development With CL Solutions and First Sales of Rapid Detection Kits
9. CryoLife Announces Management Promotions
10. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
11. Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... Proove Biosciences , ... International Spine Intervention Society’ s 23rd Annual Scientific Meeting (ASM). The ... With a focus on evidence-based research and clinical application, the event gathered industry ...
(Date:8/27/2015)... ... August 27, 2015 , ... The Kansas City Animal Health ... animal health companies to hear from animal health companies with the newest technology. ... licensing agreements or distribution contracts. This meeting is one of the only ...
(Date:8/27/2015)... PARK, Calif. , Aug. 27, 2015  Asterias ... in the emerging field of regenerative medicine, today announced ... investor conferences in the month of September.  ... will present at Rodman & Renshaw,s 17th Annual Global ... ET/7:25am PT at the St. Regis Hotel in ...
(Date:8/27/2015)... ... August 27, 2015 , ... METTLER TOLEDO's web-based EasyFinder™ ... product choices to a manageable shortlist of bench and floor scales and terminals. ... fit best with the customer’s industry and application. , Side-by-side product comparisons ...
Breaking Biology Technology:Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2METTLER TOLEDO Updates Online Scale Selection Tool 2
... Verenium Corporation (Nasdaq: VRNM ), ... high-performance industrial enzyme solutions, today announced that it ... a high performance enzyme for the saccharification of ...  The DELTAZYM® GA L-E5 enzyme has demonstrated high ...
... a three-hospital health system providing care to ... management system provided by Surgical Information Systems ... into the hospitals, existing Siemens Soarian® system ... and drive business results. (Logo: ...
... MISSISSAUGA, ON, Sept. 29 /PRNewswire-FirstCall/ - YM BioSciences ... Pulmokine Inc. (Slingerlands, New York), a licensee of ... awarded two National Institutes of Health (NIH) Small ... more than US$650,000, are Phase I awards to ...
Cached Biology Technology:Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production 2Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production 3Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 2Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 3Susquehanna Health Selects Perioperative and Anesthesia Automation Solution from Surgical Information Systems 4YM BioSciences licensee Pulmokine awarded NIH funding to develop small molecule drugs for pulmonary hypertension 2YM BioSciences licensee Pulmokine awarded NIH funding to develop small molecule drugs for pulmonary hypertension 3
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/27/2015)... , July 27, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that Huawei has selected ... solution for its stylish smartwatch. Huawei chose the ... reliability, low power and highly responsive human interface ... Huawei designers also required a classic round watch ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... . , A tip about a folk ... off bugs has led to the discovery of insect-repelling ... identified components of Jatropha curcas seed oil ... Agricultural Research Service (ARS) Natural Products Utilization Research Unit ...
... Approximately one-third of Americans take a daily multivitamin, but little ... Now, new research from Brigham and Women,s Hospital (BWH) ... of cardiovascular disease in men. A similar BWH study, ... man,s risk of cancer by 8 percent. The cardiovascular ...
... move their facial whiskers back and forth about eight times ... acquire this sense? And if they can, what could understanding ... about how humans normally sense? At the Weizmann Institute, researchers ... of blindfolded volunteers and asking them to carry out a ...
Cached Biology News:Daily multivitamin use does not reduce cardiovascular disease risk in men 2Learning a new sense 2Learning a new sense 3
... catalyzes the degradation of single-stranded DNA and ... While the nuclease prefers ssDNA over dsDNA ... enzyme degrades double-stranded DNA from both ends ... for transcript mapping studies (3,4), for flushing ...
... The S.c. EasyComp Transformation Kit is ... Saccharomyces cerevisiae cells. Advantages over commonly ... formation or LiCl methods include:- Cells can ... 30 minutes - Competent cell preparation and ...
Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....
...
Biology Products: